Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989150871> ?p ?o ?g. }
- W1989150871 endingPage "19" @default.
- W1989150871 startingPage "11" @default.
- W1989150871 abstract "Abstract Background Chromosomal abnormalities are one of the most important prognostic factors in acute myeloid leukemia (AML). However, only a limited number of patients have such informative chromosomal abnormalities. The prognostic value of immunophenotyping in this disease is still unclear. Methods Seven hundred and eighty‐three newly diagnosed AML patients treated in the German SHG‐AML trials in 1991 and 1996 were analyzed with a panel of 33 antibodies. Expression was correlated to overall survival, complete remission‐rate, and complete remission duration, and tested in a multivariate analysis including other clinical and biological markers. Results With a median follow‐up of 4.3 years, patients with AML blasts negative for CD9, CD11b, CD13, CD34, and CD41, or positive for CD15, CD33, CD38, CD64, and MPO had superior overall survival. This effect was associated with a significantly higher complete remission rate (CD13, CD34, CD41, and CD64) or a longer complete remission duration (CD9, CD11b, and CD64). Cox‐regression analysis, including cytogenetic, morphologic, and biologic parameters showed CD9, CD13, CD34, and CD64 as independent factors for overall survival. These markers were used for a prognostic score. Patients were pooled in three groups with highly significant differences of overall survival. The prognostic relevance of this score was confirmed in patients with normal karyotype and/or in younger patients ≤ 60 years. Conclusions Immunophenotyping is not only helpful for diagnosis but is of independent significance for prognosis, and may be useful for risk stratification in AML patients. Cytometry Part B (Clin. Cytometry) 53B:11–19, 2003. © 2003 Wiley‐Liss, Inc." @default.
- W1989150871 created "2016-06-24" @default.
- W1989150871 creator A5002054404 @default.
- W1989150871 creator A5006122560 @default.
- W1989150871 creator A5016639606 @default.
- W1989150871 creator A5017002895 @default.
- W1989150871 creator A5017110025 @default.
- W1989150871 creator A5039132570 @default.
- W1989150871 creator A5040820155 @default.
- W1989150871 creator A5046718799 @default.
- W1989150871 creator A5047674033 @default.
- W1989150871 creator A5052855255 @default.
- W1989150871 creator A5059745295 @default.
- W1989150871 creator A5061020169 @default.
- W1989150871 creator A5091058537 @default.
- W1989150871 date "2003-04-21" @default.
- W1989150871 modified "2023-10-17" @default.
- W1989150871 title "Immunophenotyping is an independent factor for risk stratification in AML" @default.
- W1989150871 cites W147903966 @default.
- W1989150871 cites W1496335924 @default.
- W1989150871 cites W1498501198 @default.
- W1989150871 cites W1515269506 @default.
- W1989150871 cites W1534965621 @default.
- W1989150871 cites W1558606623 @default.
- W1989150871 cites W1562680005 @default.
- W1989150871 cites W1702313568 @default.
- W1989150871 cites W1970867873 @default.
- W1989150871 cites W1982074959 @default.
- W1989150871 cites W2014454008 @default.
- W1989150871 cites W2017660057 @default.
- W1989150871 cites W2020587538 @default.
- W1989150871 cites W2022260878 @default.
- W1989150871 cites W2041562149 @default.
- W1989150871 cites W2045805176 @default.
- W1989150871 cites W2045911327 @default.
- W1989150871 cites W2047626730 @default.
- W1989150871 cites W2056148612 @default.
- W1989150871 cites W2069756834 @default.
- W1989150871 cites W2070976881 @default.
- W1989150871 cites W2078892204 @default.
- W1989150871 cites W2089751033 @default.
- W1989150871 cites W2099562174 @default.
- W1989150871 cites W2101157786 @default.
- W1989150871 cites W2132912591 @default.
- W1989150871 cites W2144749137 @default.
- W1989150871 cites W2148855592 @default.
- W1989150871 cites W2412688888 @default.
- W1989150871 cites W3111770416 @default.
- W1989150871 cites W4312790597 @default.
- W1989150871 cites W4385970358 @default.
- W1989150871 cites W86828079 @default.
- W1989150871 cites W1995674500 @default.
- W1989150871 doi "https://doi.org/10.1002/cyto.b.10030" @default.
- W1989150871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12717686" @default.
- W1989150871 hasPublicationYear "2003" @default.
- W1989150871 type Work @default.
- W1989150871 sameAs 1989150871 @default.
- W1989150871 citedByCount "47" @default.
- W1989150871 countsByYear W19891508712012 @default.
- W1989150871 countsByYear W19891508712013 @default.
- W1989150871 countsByYear W19891508712014 @default.
- W1989150871 countsByYear W19891508712015 @default.
- W1989150871 countsByYear W19891508712016 @default.
- W1989150871 countsByYear W19891508712017 @default.
- W1989150871 countsByYear W19891508712020 @default.
- W1989150871 countsByYear W19891508712021 @default.
- W1989150871 countsByYear W19891508712022 @default.
- W1989150871 crossrefType "journal-article" @default.
- W1989150871 hasAuthorship W1989150871A5002054404 @default.
- W1989150871 hasAuthorship W1989150871A5006122560 @default.
- W1989150871 hasAuthorship W1989150871A5016639606 @default.
- W1989150871 hasAuthorship W1989150871A5017002895 @default.
- W1989150871 hasAuthorship W1989150871A5017110025 @default.
- W1989150871 hasAuthorship W1989150871A5039132570 @default.
- W1989150871 hasAuthorship W1989150871A5040820155 @default.
- W1989150871 hasAuthorship W1989150871A5046718799 @default.
- W1989150871 hasAuthorship W1989150871A5047674033 @default.
- W1989150871 hasAuthorship W1989150871A5052855255 @default.
- W1989150871 hasAuthorship W1989150871A5059745295 @default.
- W1989150871 hasAuthorship W1989150871A5061020169 @default.
- W1989150871 hasAuthorship W1989150871A5091058537 @default.
- W1989150871 hasConcept C10205521 @default.
- W1989150871 hasConcept C126322002 @default.
- W1989150871 hasConcept C142724271 @default.
- W1989150871 hasConcept C143998085 @default.
- W1989150871 hasConcept C159912055 @default.
- W1989150871 hasConcept C176290653 @default.
- W1989150871 hasConcept C196166836 @default.
- W1989150871 hasConcept C203014093 @default.
- W1989150871 hasConcept C2776447464 @default.
- W1989150871 hasConcept C2778729363 @default.
- W1989150871 hasConcept C28328180 @default.
- W1989150871 hasConcept C50382708 @default.
- W1989150871 hasConcept C54355233 @default.
- W1989150871 hasConcept C553184892 @default.
- W1989150871 hasConcept C71924100 @default.
- W1989150871 hasConcept C86803240 @default.
- W1989150871 hasConcept C90924648 @default.